Showing posts with label drug development. Show all posts
Showing posts with label drug development. Show all posts

Wednesday, 27 September 2017

Biopreservation Industry Share, Growth, Analysis, Statistics, Trends, Forecast Report, 2024

The global industry report "Biopreservation Market Size By Product (Equipment, Media, Laboratory Information Management System), By Application (Regenerative Medicine, Biobanking, Drug Discovery), Industry Analysis Report, Regional Outlook (U.S., Canada, UK, Germany, Japan, China, Brazil, Mexico, South Africa), Growth Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2024" by Global Market Insights, Inc. says Biopreservation market is slated to record a double-digit annual growth rate of 13.4% over 2016-2024, with a projected revenue of USD 9.7 billion by 2024.

Integration of modern technologies in food processing to maintain the microbiological food safety standards is pushing biopreservation market globally. The market has been gaining a remarkable traction in the recent years as biopreservation defines an ecological approach that improves the safety and shelf life of the foods. Increasing consumption of precooked foods that are prone to temperature abuse has led to an increase in food related diseases across the world. Statistics depict that morbidity due to foodborne diseases accounts for a major portion. Not only lifestyle diseases, chronic illnesses like cancer, cardiovascular disease, hypertension has opened up new opportunities for biopreservation market growth. Heightening expenditures on medical services, increasing consumers’ disposable incomes, and the growing demand for regenerative medicines have significantly favored the overall biopreservation industry expansion.

Request for a sample of this research report - https://www.gminsights.com/request-sample/detail/762

The favorable initiations by the government bodies in the form of funds, grants, and financial assistance have significantly accelerated research activities in the health care sector. Growing number of biobanks across the world for the preservation of DNA, stem cells, plasma, and tissue along with the increased acceptance of ART (assisted reproductive technology) is further complementing biopreservation market dynamics. The overall industry share from bio banking dominated the application landscape in 2015 and is anticipated to continue its prominence over 2016-2024. The combined efforts by the renowned regulatory bodies including WHO, FDA, and ISBER for promoting bio preservative facilities have further provided a major impetus to the biopreservation market.

Browse key industry insights spread across 105 pages with 50 market data tables & 6 figures & charts from this 2017 report Biopreservation Market in detail along with the table of contents at:


Asia Pacific market will chart a profitable roadmap from the bio banking sector. Increasing incidence of chronic diseases, spreading awareness about preservation of umbilical cord cells, and the unmet health care needs are the major driving factors thriving the regional biopreservation market. The region’s encouraging projects on biopreservation and bio banking are quite commendable. Some of the prominent organizations who are involved in these programs include Korea Bio-bank Project, Asian Cancer Research Group, China Kadoorie Bio-bank, International Cancer Genome Consortium, and Asian Pharmacoepidemiology Network. With China and India at the growth front, APAC biopreservation market is expected to witness appreciable growth in the coming time frame.  U.S. biopreservation industry is also estimated to attain substantial revenue over the years ahead, having had a dominant position in the global landscape in 2015.

Considering the product landscape, biopreservation equipment market led the industry in 2015, by accounting for almost 80% of the overall share. Growing deployment of biopreservation equipment in health care laboratories and research centers are the factors that can be given the credit for the market expansion. Other products of the market which represents a significant share encompass LIMS (laboratory information management system) and media. Biopreservation media market will also experience steady gains owing to the technical interference in tissue engineering and regenerative medicine. Overall biopreservation market from regenerative medicine is expected to record the highest growth over the coming seven years.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/762

Mergers and acquisitions and product renovations are the major strategies adopted by the market players to sustain their position in the market. However, lack of proper regulations and funding with respect to medical data export in some of the geographies is hampering the market penetration in those regions. Nonetheless, the legislations pertaining to this market imposed by some of the renowned organizations like FDA will help biopreservation market to attain a remarkable valuation in the years ahead.

Prominent biopreservation industry participants include Thermo Fisher, Atlanta Biologicals, Lifeline Scientific, VWR International, and Biolife Solutions.


Biomedical Refrigerators And Freezers Market Size By Product (Plasma Freezers, Blood Bank Refrigerators, Lab Refrigerators, Lab Freezers, Ultra Low Temperature Freezers, Shock Freezers), By End use (Blood Banks, Pharmacies, Hospitals, Research Labs, Diagnostic Centers), Industry Analysis Report, Regional Outlook (U.S, Canada, Germany, UK, France, Spain, Italy, Russia, Ukraine, Poland, China, Japan, India, Australia, Malaysia, Indonesia, Thailand, Brazil, Mexico, Argentina, South Africa, UAE, Saudi Arabia, Qatar, Kuwait, Egypt), Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2024


Biotechnology Market Size By Technology (Fermentation, Tissue Engineering and Regeneration, PCR Technology, Nanobiotechnology, Chromatograpgy, DNA Sequencing, Cell Based Assay), By Application (Biopharmacy, Bioservices, Bioagriculture, Bioindustrial), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, China, India, Japan, South Korea, Brazil, Saudi Arabia), Growth Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2024


About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:
sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://gminsights.wordpress.com
Connect with us: Facebook | Google+ | LinkedIn | Twitter

Wednesday, 16 August 2017

Clinical Trial Management System Market share to exceed $2bn by 2024

The report “(CTMS) Clinical Trial Management System Market Size By Component (Software, Hardware, Services), By Product (Enterprise Based, Site Based), By Delivery Mode (Web, Cloud, On Premise), By End Use (Pharmaceutical & Biopharmaceutical Companies, Clinical Research Organizations, Healthcare Providers), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Poland, Russia, China, India, Japan, South Korea, Taiwan, Brazil, Mexico, South Africa), Growth Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2024”, by Global Market Insights, Inc., Clinical Trial Management System Market size is projected to hit USD 2 billion by 2024.

Rapid economic progress coupled with favorable government regulations for drug approvals will push CTMS market size in emerging economies. High investments in clinical research activities are expected to boost the demand for clinical trial management systems (CTMS) across pharmaceuticals & biopharmaceuticals firms, clinical research organizations, and healthcare sectors. In addition, rising occurrence of chronic ailments plus the increasing scope of clinical trials outsourcing is forecast to promote the business growth over the coming seven years.

CTMS market is segmented into site based clinical trial management system and enterprise based clinical trial management system. Enterprise based industry, which accounted for more than 70% of the total revenue in 2015, is anticipated to grow considerably over the coming timeframe, driven by its ability to provide specialized services. Site based CTMS is projected to contribute considerably towards the global industry share over the coming seven years.

Request for a sample of this research report -  https://www.gminsights.com/request-sample/detail/1155

Pharmaceuticals & Biopharmaceuticals application, which dominated the end-use application landscape in 2015, is forecast to hit USD 1.4 billion by 2024. Tremendous efforts by market players to manufacture new medicines for treating chronic ailments is expected to boost the revenue. CTMS industry size in clinical research organizations is expected to grow at a rate of 14% over 2016-2024, driven by rise in clinical trial outsourcing activities along with high investments in R&D for clinical research business.

Regional highlights of Clinical Trial Management System Market over 2016-2024 are given below:

China CTMS industry revenue is forecast to produce more than USD 270 million by 2024. Government initiatives to establish research centers along with high spending on research activities across pharmaceuticals, life sciences, and clinical research sectors will drive regional growth.

Beneficial regulations such as allocation of funds for NIH, NCI, and FDA to carry out intense research and develop new healthcare solutions will propel U.S. clinical trial management system market value over the next few years.

Browse key industry insights spread across 105 pages with 92 data tables & 6 figures & charts from the report, ““(CTMS) Clinical Trial Management System Market” in detail along with the table of contents:


Brazil CTMS industry is forecast to cross USD 55 million by 2024, driven by new breakthroughs in clinical research, growing popularity of biomedical equipment, and enhanced use of modern healthcare systems.
Government rules supporting clinical research are expected to boost CTMS market expansion in Germany over the years to come. Germany CTMS industry revenue is forecast to hit USD 180 million by 2024.

India clinical trial management system market value, which was estimated at USD 50 million in 2015, is anticipated to witness a remarkable growth over the coming years. Technological advancements in healthcare coupled with increasing investment in clinical research activities is projected to spur the regional revenue.

Key industry players include eClinForce Incorporation, MedNet Solutions Incorporation, Forte Research Systems Incorporation, Medidata solutions, Bio-Optronics Incorporation, PAREXEL International Corporation, Merge Healthcare Incorporation, VEEVA Systems, Oracle Corporation, and BioClinica Company.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/1155

Table of Contents 

Chapter 1.    Methodology and Scope

1.1.    Research Methodology                
1.1.1.    Initial data exploration
1.1.2.    Statistical model and forecast
1.1.3.    Industry insights and validation
1.1.4.    Research scope and assumptions                
1.2.    Data Sources
1.2.1.    Primary sources
1.2.2.    Secondary sources

Chapter 2.    Executive Summary

2.1.    Clinical Trial Management System industry 3600 synopsis, 2012 – 2024
2.1.1.    Business trends
2.1.2.    Regional trends
2.1.3.    Application trends

Chapter 3.    Clinical Trial Management System Industry Insights

3.1.    Industry segmentation
3.2.    Industry size and forecast, 2012 – 2024
3.3.    Industry impact forces
3.3.1.    Growth drivers
3.3.1.1.    Outsourcing of clinical trails 
3.3.1.2.    Enhanced R&D expenditure of life science and clinical research industries 
3.3.1.3.    Increased number of clinical trials
3.3.2.    Industry pitfalls & challenges
3.3.2.1.    High cost of Clinical Trial Management System 
3.4.    Growth potential analysis
3.5.    Regulatory landscape
3.5.1.    U.S.
3.5.2.    Europe
3.5.3.    China
3.6.    Software landscape
3.7.    Porter’s analysis
3.8.    PESTEL analysis
3.9.    Competitive landscape, 2015
3.9.1.    Strategy dashboard

Browse Related Reports:

Clinical Laboratory Services Market Size By Test (Human & Tumor Genetics, Clinical Chemistry, Medical Microbiology & Cytology, Other Esoteric Test), By Service Provider (Hospitals, Stand-Alone Laboratories, Clinics), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, Japan, China, Brazil, Mexico, South Africa), Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2024


About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://gminsights.wordpress.com
Connect with us: Facebook | Google+ | LinkedIn | Twitter